References
1. Nyati KK, Prasad KN: Role
of cytokines and Toll-like receptors in the immunopathogenesis of
Guillain-Barre syndrome . Mediators of inflammation 2014,2014 :758639.
2. Jasti AK, Selmi C, Sarmiento-Monroy
JC, Vega DA, Anaya JM, Gershwin ME: Guillain-Barre syndrome:
causes, immunopathogenic mechanisms and treatment . Expert review
of clinical immunology 2016, 12 (11):1175-1189.
3. Zhang HL, Zheng XY, Zhu J:Th1/Th2/Th17/Treg cytokines in Guillain-Barre syndrome and
experimental autoimmune neuritis . Cytokine & growth factor
reviews 2013, 24 (5):443-453.
4. Duan RS, Zhang XM, Mix E, Quezada
HC, Adem A, Zhu J: IL-18 deficiency inhibits both Th1 and Th2
cytokine production but not the clinical symptoms in experimental
autoimmune neuritis . J Neuroimmunol 2007,183 (1-2):162-167.
5. Banerjee S, Cui H, Xie N, Tan Z,
Yang S, Icyuz M, Thannickal VJ, Abraham E, Liu G: miR-125a-5p
regulates differential activation of macrophages and inflammation .The Journal of biological chemistry 2013,288 (49):35428-35436.
6. Malyshev I, Malyshev Y:Current Concept and Update of the Macrophage Plasticity Concept:
Intracellular Mechanisms of Reprogramming and M3 Macrophage ”Switch”
Phenotype . Biomed Res Int 2015, 2015 :341308.
7. Han R, Xiao J, Zhai H, Hao J:Dimethyl fumarate attenuates experimental autoimmune neuritis
through the nuclear factor erythroid-derived 2-related factor
2/hemoxygenase-1 pathway by altering the balance of M1/M2 macrophages .Journal of neuroinflammation 2016, 13 (1):97.
8. Nyati KK, Prasad KN, Rizwan A,
Verma A, Paliwal VK: TH1 and TH2 response to Campylobacter
jejuni antigen in Guillain-Barre syndrome . Archives of neurology2011, 68 (4):445-452.
9. Kiefer R, Kieseier BC, Stoll G,
Hartung HP: The role of macrophages in immune-mediated damage to
the peripheral nervous system . Progress in neurobiology 2001,64 (2):109-127.
10. Jin T, Yu H, Wang D, Zhang H,
Zhang B, Quezada HC, Zhu J, Zhu W: Bowman-Birk inhibitor
concentrate suppresses experimental autoimmune neuritis via shifting
macrophages from M1 to M2 subtype . Immunology letters 2016,171 :15-25.
11. Han R, Gao J, Zhai H, Xiao J,
Ding Y, Hao J: RAD001 (everolimus) attenuates experimental
autoimmune neuritis by inhibiting the mTOR pathway, elevating Akt
activity and polarizing M2 macrophages . Experimental neurology2016, 280 :106-114.
12. Hayden MS, West AP, Ghosh S:NF-kappaB and the immune response . Oncogene 2006,25 (51):6758-6780.
13. Pires BRB, Silva R, Ferreira GM:NF-kappaB: Two Sides of the Same Coin . 2018, 9 (1).
14. Sica A, Mantovani A:Macrophage plasticity and polarization: in vivo veritas .J Clin Invest 2012, 122 (3):787-795.
15. Zhu J, Mix E, Link H:Cytokine production and the pathogenesis of experimental
autoimmune neuritis and Guillain-Barre syndrome . J Neuroimmunol1998, 84 (1):40-52.
16. Mantovani A, Biswas SK, Galdiero
MR, Sica A, Locati M: Macrophage plasticity and polarization in
tissue repair and remodelling . The Journal of pathology 2013,229 (2):176-185.
17. Shen D, Chu F, Lang Y, Geng Y,
Zheng X, Zhu J, Liu K: Beneficial or Harmful Role of Macrophages
in Guillain-Barre Syndrome and Experimental Autoimmune Neuritis .Mediators Inflamm 2018, 2018 :4286364.
18. Laskin DL: Macrophages
and inflammatory mediators in chemical toxicity: a battle of forces .Chemical research in toxicology 2009, 22 (8):1376-1385.
19. Zhang HL, Hassan MY, Zheng XY,
Azimullah S, Quezada HC, Amir N, Elwasila M, Mix E, Adem A, Zhu J:Attenuated EAN in TNF-alpha deficient mice is associated with an
altered balance of M1/M2 macrophages . PloS one 2012,7 (5):e38157.
20. Liu G, Ma H, Qiu L, Li L, Cao Y,
Ma J, Zhao Y: Phenotypic and functional switch of macrophages
induced by regulatory CD4+CD25+ T cells in mice . Immunology and
cell biology 2011, 89 (1):130-142.
21. McWhorter FY, Davis CT, Liu WF:Physical and mechanical regulation of macrophage phenotype and
function . Cellular and molecular life sciences : CMLS 2015,72 (7):1303-1316.
22. Ghosh S, May MJ, Kopp EB:NF-kappa B and Rel proteins: evolutionarily conserved mediators
of immune responses . Annual review of immunology 1998,16 :225-260.
23. Andorfer B, Kieseier BC, Mathey
E, Armati P, Pollard J, Oka N, Hartung HP: Expression and
distribution of transcription factor NF-kappaB and inhibitor IkappaB in
the inflamed peripheral nervous system . Journal of
neuroimmunology 2001, 116 (2):226-232.
24. Laura M, Mazzeo A, Aguennouz M,
Santoro M, Catania MA, Migliorato A, Calapai G, Vita G:Immunolocalization and activation of nuclear factor-kappaB in
the sciatic nerves of rats with experimental autoimmune neuritis .Journal of neuroimmunology 2006, 174 (1-2):32-38.
25. Barnes PJ, Karin M:Nuclear factor-kappaB: a pivotal transcription factor in chronic
inflammatory diseases . The New England journal of medicine 1997,336 (15):1066-1071.
26. Hayden MS, Ghosh S:NF-kappaB in immunobiology . Cell research 2011,21 (2):223-244.
27. Al-Sayeqh AF, Loughlin MF, Dillon
E, Mellits KH, Connerton IF: Campylobacter jejuni activates
NF-κB independently of TLR2, TLR4, Nod1 and Nod2 receptors .Microbial pathogenesis 2010, 49 (5):294-304.
28. Lawrence T: The nuclear
factor NF-kappaB pathway in inflammation . Cold Spring Harbor
perspectives in biology 2009, 1 (6):a001651.
29. Chiarugi A:Characterization of the molecular events following impairment of
NF-κB-driven transcription in neurons . Molecular brain research2002, 109 (1-2):179-188.
30. Nickols JC, Valentine W, Kanwal
S, Carter BD: Activation of the transcription factor NF-κB in
Schwann cells is required for peripheral myelin formation . Nature
neuroscience 2003, 6 (2):161.
31. Kassed CA, Butler TL, Patton GW,
DEMESQUITA DD, Navidomskis MT, Mémet S, Israël A, Pennypacker KR:Injury-induced NF-κB activation in the hippocampus: implications
for neuronal survival . The FASEB journal 2004,18 (6):723-724.
32. Bhakar AL, Tannis L-L, Zeindler
C, Russo MP, Jobin C, Park DS, MacPherson S, Barker PA:Constitutive nuclear factor-κB activity is required for central
neuron survival . Journal of Neuroscience 2002,22 (19):8466-8475.
33. Alcamo E, Mizgerd JP, Horwitz BH,
Bronson R, Beg AA, Scott M, Doerschuk CM, Hynes RO, Baltimore D:Targeted mutation of TNF receptor I rescues the RelA-deficient
mouse and reveals a critical role for NF-kappa B in leukocyte
recruitment . Journal of immunology (Baltimore, Md : 1950) 2001,167 (3):1592-1600.